Evolus Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Evolus Inc 's inventory turnover ratio, the ratio that measures Evolus Inc 's ability to manage its supply chain, sequentially decreased to 3.71 in the first quarter 2026, which does not come as a surprise, as the Evolus Inc continue to experience headwinds, which also impact its supply chain. Evolus Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 98 days, from 88 days, in the Dec 31 2025 quarter.

Within Healthcare sector 103 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 713 in the fourth quarter 2025, to 744.

EOLS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Evolus Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EOLS Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	147.32 %	121.77 %	120.73 %	97.72 %	-13.17 %
Y / Y Cost of Sales Growth	14.29 %	11.88 %	26.21 %	25.81 %	16.23 %
Inventory Turnover Ratio (TTM)	3.71	4.15	4.74	5.78	6.89
EOLS's Total Ranking	# 744	# 713	# 655	# 736	# 519
Average inventory processing period	98	88	77	63	53
Seq. Inventory Growth	-8.04 %	-17.97 %	24.24 %	163.88 %	-17.54 %
Seq. Cost of Sales Growth	-25 %	39.13 %	-4.17 %	14.29 %	-26.58 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 21
Healthcare Sector	# 104
Overall Market	# 744

Inventory Turnover Ratio Statistics
High	Average	Low
16.55	5.41	1.05
(Mar 31 2022)		(Dec 31 2019)

EOLS Company Profile >> Back to EOLS Efficiency Comparisons >> Compare EOLS Inventory Turnover Ratio to its Competitors

Financial Statements
Evolus Inc 's Inventories	$ 25 Millions	Visit EOLS's Balance sheet
Evolus Inc 's Cost of Revenues TTM	$ 103 Millions	Visit EOLS's Income Statement
What are EOLS's Sales?		Visit EOLS's Sales by Segment

Other Inventory Turnover Ratios
Evolus Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
EOLS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for EOLS's Competitors
Inventory Turnover Ratio for EOLS's Suppliers
Inventory Turnover Ratio for EOLS's Customers

You may also want to know
EOLS's Sales Growth Rates	EOLS's Pe Price to earnings ratio	EOLS's Receivables Turnover Ratio	EOLS's Stock Quote
EOLS's Net Income Growth Rates	EOLS's Ps Price to Sales ratio	EOLS's Sales per Employee	EOLS's Asset Turnover Ratio
EOLS's Net Margin	EOLS's Pb Price to Book ratio	EOLS's Financial Strength Ratios	EOLS's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
The Oncology Institute Inc	11.17	$ 211.805 Millions	$ 19 Millions
Genedx Holdings Corp	11.09	$ 135.000 Millions	$ 12 Millions
Infusystem Holdings Inc	10.96	$ 61.593 Millions	$ 6 Millions
Irhythm Holdings Inc	10.94	$ 228.000 Millions	$ 21 Millions
Earth Science Tech Inc	10.81	$ 8.224 Millions	$ 1 Millions
Option Care Health Inc	10.74	$ 4,579.720 Millions	$ 427 Millions
Zevra Therapeutics Inc	10.44	$ 17.034 Millions	$ 2 Millions
Alnylam Pharmaceuticals Inc	10.38	$ 814.503 Millions	$ 78 Millions
Nutriband Inc	10.06	$ 1.291 Millions	$ 0 Millions
Lantheus Holdings Inc	9.75	$ 610.000 Millions	$ 63 Millions
Sotera Health Company	9.58	$ 531.000 Millions	$ 55 Millions
Warby Parker Inc	9.23	$ 415.000 Millions	$ 45 Millions
Tarsus Pharmaceuticals Inc	9.09	$ 37.864 Millions	$ 4 Millions
National Vision Holdings Inc	8.90	$ 833.415 Millions	$ 94 Millions
Myriad Genetics Inc	8.35	$ 248.000 Millions	$ 30 Millions
Pulse Biosciences Inc	8.08	$ 0.909 Millions	$ 0 Millions
Castle Biosciences Inc	7.97	$ 75.178 Millions	$ 9 Millions
Moderna Inc	7.96	$ 1,733.000 Millions	$ 218 Millions
Carlsmed Inc	7.95	$ 12.557 Millions	$ 2 Millions
Inogen Inc	7.80	$ 195.741 Millions	$ 25 Millions
Cardiff Lexington Corporation	7.70	$ 4.159 Millions	$ 1 Millions
Novavax inc	7.67	$ 89.620 Millions	$ 12 Millions
Prophase Labs Inc	7.64	$ 2.361 Millions	$ 0 Millions
Bellevue Life Sciences Acquisition Corp	7.62	$ 1.986 Millions	$ 0 Millions
Lifemd Inc	7.60	$ 24.000 Millions	$ 3 Millions
Charles River Laboratories International inc	7.56	$ 2,346.239 Millions	$ 310 Millions
Adaptive Biotechnologies Corporation	7.43	$ 73.088 Millions	$ 10 Millions
Puma Biotechnology Inc	7.19	$ 58.025 Millions	$ 8 Millions
Fonar Corporation	7.06	$ 19.685 Millions	$ 3 Millions
Carlisle Companies Incorporated	6.71	$ 3,206.100 Millions	$ 478 Millions

Date modified: 2026-08-29T17:39:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.